Table of Contents
Clinical Summary:
The Gap: Physical therapy for functional motor disorder has been recommended for years but with limited high-quality RCT evidence. The Physio4FMD trial filled that gap with the largest randomized comparison to date.
The Evidence: 355 adults with functional motor disorder randomized to specialist physiotherapy or community-based neurological physiotherapy across England and Scotland. Primary outcome (SF-36 PF) did not reach statistical significance, but specialist arm showed significantly better patient-rated motor symptom improvement, mental health, and well-being.
The Takeaway: Physio4FMD established that PT for functional motor disorder is safe, effective, and FND-specific training improves outcomes over generic neurological physiotherapy. The protocol parameters (9 sessions plus follow-up) are now a real-world benchmark.
For decades, the question of whether physical therapy for functional motor disorder actually works was answered with "probably, but we need better evidence." Case series, observational studies, and small trials all pointed in the same favorable direction, but a large, methodologically rigorous randomized controlled trial was missing from the literature.
The Physio4FMD trial filled that gap. 355 adults with functional motor disorder. Randomized across multiple centers in England and Scotland. Specialist physiotherapy delivered by clinicians trained specifically in FND management compared to community-based neurological physiotherapy. The largest RCT to date on this question.
The findings are nuanced and clinically important. This page walks through what the trial actually showed, what it did and did not establish, and how the results translate to clinical practice for non-specialist clinicians who treat FND patients in their caseload.
The Trial Design
Physio4FMD was a pragmatic, multicenter phase 3 RCT. The pragmatic design is important: it tested specialist physiotherapy as it would actually be delivered in real-world clinical practice, against the comparator that real patients with FND would otherwise receive (community-based neurological physiotherapy).
Population: 355 adults with functional motor disorder, recruited across multiple UK centers. Diagnostic confirmation by neurology using positive signs.
Intervention: Specialist physiotherapy delivered by PTs trained specifically in FND management. The treatment protocol included education about FND, distraction-based movement retraining, automatic movement strategies, and graded functional rehabilitation. Nine treatment sessions plus a follow-up session.
Comparator: Community-based neurological physiotherapy as usually delivered, physiotherapy from clinicians who treat various neurological conditions but without specific FND training.
Primary outcome: SF-36 physical functioning subscale at 12 months.
Secondary outcomes: Patient-rated motor symptom improvement, mental health, subjective well-being, healthcare utilization, and adverse events.
Follow-up: 12 months post-intervention initiation, with blinded outcome assessment.
What the Trial Found
Primary outcome: The SF-36 physical functioning subscale at 12 months did not reach statistical significance between the specialist and community arms. Adjusted mean difference 3.5 points; 95% CI -2.3 to 9.3. This finding initially attracted attention as a "negative trial" result, but the interpretation requires nuance.
Both arms received active physiotherapy intervention. The trial was not comparing specialist PT to no PT. It was comparing specialist FND-trained PT to non-specialist neurological PT. The modest between-group difference on the primary outcome may reflect that both groups improved meaningfully, rather than that specialist PT lacks benefit.
Secondary outcomes revealed clearer benefits:
- Patient-rated motor symptom improvement: Significantly more participants in the specialist arm self-rated their motor symptoms as improved at 12 months.
- Mental health: Specialist physiotherapy was associated with better scores on mental health and subjective well-being measures.
- Safety: Both interventions were safe. No serious adverse events related to physiotherapy were reported.
- Acceptability: Patient engagement and adherence supported specialist PT as acceptable to FND populations.
Physio4FMD Sample Size:
355
Adults randomized across England and Scotland. The largest RCT of physiotherapy for functional motor disorder to date.
What This Means for Clinical Practice
Several practical implications follow from the trial findings:
1. PT for functional motor disorder is safe and effective. Both arms produced meaningful improvement. The conversation about FND rehabilitation can now reference RCT-level evidence, not just case series and clinical experience.
2. FND-specific PT training improves outcomes over generic neurological PT. The specialist arm showed significantly better patient-rated improvement and mental health outcomes. The practical implication: if you're a PT treating FND patients, FND-specific training pays off in patient-reported outcomes. If you're a clinician referring FND patients to PT, ideally refer to PTs with FND-specific expertise.
3. Patient-rated improvement matters and often exceeds objective testing improvement. The secondary outcomes that favored specialist PT were largely patient-reported. This is consistent with FND broadly, symptoms are often more responsive to intervention than blinded objective testing can fully capture. Clinical decision-making should prioritize patient-reported outcomes alongside objective measures.
4. The intervention parameters (9 sessions plus follow-up) are a real-world benchmark. Clinicians can use these parameters to advocate for adequate session allocation and to set realistic expectations with patients about treatment duration.
5. The trial supports multidisciplinary care but did not test it directly. Physio4FMD was a PT-focused trial. The Macías-García RCT separately established that combined PT plus CBT outperforms psychological support alone. Together, these trials support multidisciplinary rehabilitation as the standard.
Physio4FMD established that PT for functional motor disorder is safe, acceptable, and effective. The specialist version outperforms generic neurological PT on patient-rated outcomes. That's enough to change practice.
What Specialist PT Looks Like
The Physio4FMD specialist intervention is well-described in the trial publications and supporting protocol papers. Core elements:
Patient education about FND. Explanation of the diagnosis, the underlying mechanism, the rationale for the PT approach. Reinforces the diagnostic conversation from neurology.
Distraction-based motor retraining. Engage the patient in cognitive or non-affected-limb tasks while attempting movement in the affected region. The intact motor pathways activate more readily when conscious focus is redirected away from the symptomatic body part.
Automatic movement strategies. Novel motor tasks (walking backward, altered rhythm, unfamiliar movement sequences) that bypass entrenched abnormal patterns and engage motor planning in different ways.
Graded functional rehabilitation. Progressive advancement from basic movement patterns to more complex functional activities. Each stage built on demonstrated capability rather than against perceived weakness. Quality of movement prioritized over quantity.
Demonstration of preserved function. Positive signs (Hoover's, drift without pronation, tremor entrainment when relevant) used as therapeutic demonstrations, showing the patient that the underlying system is intact and capable.
What it does NOT include: strengthening exercises for functional weakness; compensation through mobility aids unless safety requires; stroke-style protocols.
Product Spotlight:
Functional Neurological Disorders for the Non-Specialist Clinician
$37.97
This continuing education course equips healthcare professionals with the essential skills to confidently recognize, diagnose, and manage Functional Neurological Disorders (FND) - one of the most common yet frequently misunderstood conditions encountered across healthcare settings. Grounded in the latest neuroscience,… read more
The Trial's Limitations
Several limitations are worth noting:
The primary outcome did not reach statistical significance. This affects how strongly the trial can be cited as definitive evidence for specialist over community PT. The secondary outcome benefits are real and clinically meaningful, but the primary outcome miss is a real limitation.
Both arms received active intervention. This means the trial cannot answer "does PT work compared to no PT?", it can only answer "does specialist PT work better than community PT?" The implication for clinicians without access to specialist-trained PT is that community-delivered neurological physiotherapy is also producing meaningful benefit, not no benefit.
The follow-up was 12 months. Durability of effects beyond that window is not directly addressed by this trial.
The population was UK adults with confirmed functional motor disorder. Generalizability to other populations (US, Australia, lower-resource settings) and to FND subtypes other than motor disorder requires extrapolation.
Despite these limitations, Physio4FMD remains the most robust evidence available and substantially supports specialist PT for functional motor disorder.
For Clinicians Without FND-Specific Training
Many non-specialist clinicians will encounter FND patients in caseloads without having received FND-specific training. Some practical considerations:
The general principles of FND-specific PT (distraction-based, automatic movement, redirection of attention, novel motor tasks) are learnable from published protocols, video resources, and CE programs. The Physio4FMD intervention is described in detail in the supporting publications.
Even community-delivered neurological PT produces meaningful improvement in the trial comparator arm. Applying basic FND-aware principles (avoiding strengthening-focused programs, using distraction, validating the diagnosis) is better than nothing while specialist training is developed.
Referral to specialist programs where available is preferable for complex presentations. In many regions, dedicated FND programs are concentrated in academic medical centers; awareness of available referral resources is part of practice.
Coordination with neurology, psychology, and OT supports multidisciplinary care that no single discipline can deliver alone.
No serious adverse events were associated with physiotherapy in either arm of the Physio4FMD trial. This is a notable finding given the historical concern that aggressive rehabilitation of FND patients might exacerbate symptoms or trigger psychological decompensation. The trial supports the safety of active PT intervention even in patients with significant functional motor symptoms.
How Physio4FMD Fits in the Broader Evidence Base
The Physio4FMD trial is one of three pieces of recent evidence that have most directly shaped contemporary FND treatment recommendations:
Physio4FMD established PT efficacy for functional motor disorder.
Macías-García RCT demonstrated that combined PT plus CBT produces greater improvements than psychological support alone.
Multidisciplinary program evaluations (outpatient and inpatient) confirmed that comprehensive programs reduce ED utilization and improve motor, mood, and quality of life outcomes.
Together, these establish the multidisciplinary rehabilitation model as the contemporary standard. The full operating model is in the FND clinician's guide pillar. The rehabilitation breakdown is in the FND rehabilitation framework. The diagnostic communication that opens the door to this rehabilitation is in the diagnostic communication framework.
The Bottom Line
The Physio4FMD trial established that physical therapy for functional motor disorder is safe, effective, and improved by FND-specific training. 355 adults randomized across the UK. Patient-rated improvement, mental health, and well-being all favored specialist physiotherapy. The trial's nine-session-plus-follow-up protocol is now the real-world benchmark. The clinician who treats FND patients without referencing this evidence is operating from a pre-2024 framework that the patient population has moved past.
FAQs
If the Physio4FMD trial primary outcome was not statistically significant, why is it considered to support specialist PT?
The primary outcome was the SF-36 physical functioning subscale at 12 months. The secondary outcomes (patient-rated motor symptom improvement, mental health, well-being) showed significant benefits favoring the specialist arm. Both interpretations are accurate: the trial did not confirm the specific primary hypothesis at the pre-specified level, and it did demonstrate clinically meaningful secondary benefits. The overall interpretation supports specialist PT for functional motor disorder with the noted caveats.
Does the Physio4FMD trial apply to functional seizures or other FND subtypes?
No. The trial enrolled patients with functional motor disorder specifically. Functional seizures, functional sensory symptoms, functional cognitive disorder, and other subtypes were not the trial population. The general principles of FND-specific PT may apply across subtypes, but the specific RCT evidence is for functional motor disorder. CBT evidence is particularly strong in functional seizures and is the more relevant intervention pathway for that subtype.
What is the recommended dose of PT based on the Physio4FMD trial?
Nine sessions plus a follow-up session, delivered by PTs with FND-specific training. This is the protocol that produced the trial results. Real-world programs may vary based on resource availability and individual patient presentation, but the trial dose is a defensible benchmark for advocating for adequate session allocation.
Can a community-based PT without FND specialist training still treat FND patients effectively?
Yes. The community-PT arm of Physio4FMD produced meaningful improvement, just less than the specialist arm. Community-based clinicians applying basic FND-aware principles, distraction-based work, avoidance of strengthening-focused programs, validation of the diagnosis, coordination with multidisciplinary team, can deliver effective care. Specialist training improves outcomes when available. Lack of specialist training is not a reason to deny PT treatment.
How does the Physio4FMD trial change what I should refer FND patients for?
It supports referral to PT as a first-line intervention for functional motor disorder, ideally to PTs with FND-specific expertise. It also supports the multidisciplinary model when combined with the Macías-García evidence on PT plus CBT. The previous default of "refer to psychiatry" is not supported as primary management; the contemporary default is multidisciplinary care with PT as a core component.
